Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely ...

Switching from IV to subcutaneous injection eases hard vein access, cuts clinic time, and boosts comfort with faster ...

Dr. Marc Hurlbert discusses how immunotherapy is improving outcomes and why early detection remains key as melanoma cases ...

Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely to die of myocarditis, and myocarditis-specific fatality was more common in ...

A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...

Nanobiotix ( (NBTX)) has issued an update. On April 20, 2026, Nanobiotix reported new preclinical data for its Nanoprimer platform, presented at the American Association for Cancer Research annual ...

A coroner has urged changes to the care of cancer patients following the death of a man in hospital in Sheffield following ...

For years, a lung cancer diagnosis often came with devastating odds. Survival was short hope was scarce. That narrative is ...

Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of post-op chemotherapy have remained cancer-free after almost three years of ...

Advancements in both detecting and curing cancer have resulted in a higher percentage of people surviving five years or more ...

It’s been nearly a year since my lumpectomy and the stiffness that came on immediately after, still lingers. My ...

Mendus AB ("Mendus" publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies for myeloid blood cancers, today announced that the first patient has been enrolled in the VITAL-CML trial, w ...